|
|
7:30 AM - 8:30 AM | Registration and Continental Breakfast | |
|
8:30 AM - 8:45 AM | Introduction and Welcome Dr. Lawrence Tabak, D.D.S., Ph.D., Director, National Institute for Dental and Craniofacial Research, Pain Consortium Co-Chair | |
|
8:45 AM - 9:00 AM | Message from the American Pain Society | |
|
| Session One: Developing Tools for Individualized Pain Management | |
|
9:00 AM - 9:20 AM | Harvard Medical School: Assessment Tools to Characterize Individual Pain Phenotypes Clifford Woolf, M.B., B.Ch., Ph.D., Children's Hospital Boston, Harvard Medical School | |
|
9:20 AM - 9:40 AM | Developing Imaging Biomarkers of Analgesic Effects David Borsook, M.D., Ph.D., McLean Hospital, Harvard University | |
|
9:40 AM - 10:00 AM | Methodology for Adaptive Treatment Strategies for Chronic Disorders: Focus on Pain Susan A. Murphy, Ph.D., University of Michigan | |
|
10:00 AM - 10:20 AM | Moving from the Means to the Standard Deviations in Pain Research: Novel Approaches to Characterize Christine Miaskowski, R.N., Ph.D., FAAN, University of California, San Francisco | |
|
10:20 AM - 10:40 AM | Questions and Answers: Panel | |
|
10:40 AM - 11:00 AM | Break and Posters Poster presentations will be held outside the auditorium. | |
|
| Session 2: Translating Research into Tailored Clinical Practice | |
|
11:00 AM - 11:20 AM | Identifying Risk Factors for Post-Surgical Pain Robert Edwards, Ph.D., Brigham and Women's Hospital, Harvard University | |
|
11:20 AM - 11:40 AM | Trends and Risks of Chronic Opioid Therapy Among the Elderly Michael Von Korff, Ph.D., Group Health Research Institute | |
|
11:40 AM - 12:00 PM | Psychopathology as a Predictor of the Efficacy of Pain Management Strategies Ajay D. Wasan, M.D., Brigham and Women's Hospital, Harvard University | |
|
12:00 PM - 12:20 PM | Pain in Rheumatoid Arthritis: More Than Inflammation Daniel Solomon, M.D., Ph.D., Brigham and Women's Hospital, Harvard University | |
|
12:20 PM - 12:40 PM | Questions and Answers: Panel | |
|
12:40 PM - 2:00 PM | Lunch Break and Posters Poster presentations will be held outside the auditorium. | |
|
2:00 PM - 2:10 PM | Presentation of the Mitchell Max Award for Best Poster Story Landis, Ph.D., Director, National Institute for Neurological Disorders and Stroke, Pain Consortium Co-Chair | |
|
2:10 PM - 2:10 PM | Session 3: Emerging Therapies for Individualized Pain Management | |
|
2:10 PM - 2:30 PM | Targeted Nerve Toxin for Cancer Pain Michael Iadarola, Ph.D., National Institute for Dental and Craniofacial Research | |
|
2:30 PM - 2:50 PM | Emerging Therapies for Pain Management: Glial Targets Linda Watkins, Ph.D., University of Colorado, Boulder | |
|
2:50 PM - 3:10 PM | Central Role of Protein Kinase-C Epsilon in Mediating Analgesic Synergy in Primary Afferent Terminals George Wilcox, Ph.D., University of Minnesota | |
|
3:10 PM - 3:30 PM | Emerging Therapies for Pain Management: Spinal Analgesics James Eisenach, M.D., Wake Forest University | |
|
3:30 PM - 3:50 PM | Questions and Answers: Panel | |
|
3:50 PM - 3:50 PM | Closing Remarks Josephine Briggs, M.D., Director, National Center for Complementary and Alternative Medicine, Pain Consortium Co-Chair | |
|
No comments:
Post a Comment